Intra-Articular Administration of Ganglioside Sugars Protects Cartilage from Progressive Degeneration in an Instability OA Rabbit Model

Overview

Journal Cartilage

Date 2025 Jan 15

PMID 39810328

Authors

Masanari Hamasaki

Tomohiro Onodera

Junichi Furukawa

Masahiro Todoh

Yuma Sakai

Taku Ebata

Mohamad Alaa Terkawi

Kentaro Homan

Norimasa Iwasaki

Affiliations

Soon will be listed here.

Abstract

Objective: Osteoarthritis (OA) is a degenerative joint disease that has no cure, and current therapies are intended to minimize pain. There is, therefore, a need for effective pharmacologic agents that reverse or slow the progression of joint damage. We report herein on an investigation of the effects of intra-articular injections of ganglioside sugars on the progression of OA in an experimental rabbit model.

Design: Knee OA was induced Japanese in White rabbits by anterior cruciate ligament transection (ACLT). Ganglioside sugars at concentrations of 0.1, 0.3, and 0.9 mg/ml were then intra-articularly injected as a possible treatment for OA. Controls received intra-articular injections of saline. Knees were assessed macroscopically, histologically, and mechanically at 13 weeks after ACLT induction.

Results: Macroscopically, knees of the groups that received ganglioside sugars at concentrations of 0.3 and 0.9 mg/ml exhibited milder cartilage degradation compared to the controls. Consistent with these results, histological scores for these knees were significantly higher than the corresponding values for the control knees. Lectin histochemistry staining revealed that the treatment with ganglioside sugars at concentrations of 0.3 and 0.9 mg/ml was associated with a remarkable increase in the levels of GalNAc-positive chondrocytes in cartilage. Coefficient of friction testing also demonstrated that cartilages treated with ganglioside sugars had a lower coefficient of frictions than the values for the control group.

Conclusions: Intra-articular injections of ganglioside sugars prevented cartilage degeneration in an OA-instability model. These results highlight the promising therapeutic potential for using ganglioside sugars in the treatment of progressive OA.

References

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

Laverty S, Girard C, Williams J, Hunziker E, Pritzker K . The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage. 2010; 18 Suppl 3:S53-65. DOI: 10.1016/j.joca.2010.05.029. View

Kawano T, Miura H, Mawatari T, Moro-oka T, Nakanishi Y, Higaki H . Mechanical effects of the intraarticular administration of high molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis Rheum. 2003; 48(7):1923-9. DOI: 10.1002/art.11172. View

Setton L, Elliott D, Mow V . Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis Cartilage. 1999; 7(1):2-14. DOI: 10.1053/joca.1998.0170. View

Suh H, Lee H, Min B, Jung S, Jung E . Effects of gangliosides from deer bone extract on the gene expressions of matrix metalloproteinases and collagen type II in interleukin-1β-induced osteoarthritic chondrocytes. Nutr Res Pract. 2016; 10(6):569-574. PMC: 5126405. DOI: 10.4162/nrp.2016.10.6.569. View

Igarashi T, Iwasaki N, Kawamura D, Tsukuda Y, Kasahara Y, Todoh M . Therapeutic Effects of Intra-Articular Ultrapurified Low Endotoxin Alginate Administration on Experimental Osteoarthritis in Rabbits. Cartilage. 2015; 3(1):70-8. PMC: 4297190. DOI: 10.1177/1947603511418959. View

Todeschini A, Hakomori S . Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 2007; 1780(3):421-33. PMC: 2312458. DOI: 10.1016/j.bbagen.2007.10.008. View

Urita A, Matsuhashi T, Onodera T, Nakagawa H, Hato M, Amano M . Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage. Arthritis Rheum. 2011; 63(11):3428-38. DOI: 10.1002/art.30584. View

Toegel S, Bieder D, Andre S, Altmann F, Walzer S, Kaltner H . Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein. Arthritis Res Ther. 2013; 15(5):R147. PMC: 3978707. DOI: 10.1186/ar4330. View

10.

Sah R, Yang A, Chen A, Hant J, Halili R, Yoshioka M . Physical properties of rabbit articular cartilage after transection of the anterior cruciate ligament. J Orthop Res. 1997; 15(2):197-203. DOI: 10.1002/jor.1100150207. View

11.

Ratneswaran A, Rockel J, Kapoor M . Understanding osteoarthritis pathogenesis: a multiomics system-based approach. Curr Opin Rheumatol. 2019; 32(1):80-91. DOI: 10.1097/BOR.0000000000000680. View

12.

Ichikawa S, Hirabayashi Y . Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998; 8(5):198-202. DOI: 10.1016/s0962-8924(98)01249-5. View

13.

Teeple E, Elsaid K, Fleming B, Jay G, Aslani K, Crisco J . Coefficients of friction, lubricin, and cartilage damage in the anterior cruciate ligament-deficient guinea pig knee. J Orthop Res. 2007; 26(2):231-7. PMC: 2792715. DOI: 10.1002/jor.20492. View

14.

Masoud I, Shapiro F, Kent R, Moses A . A longitudinal study of the growth of the New Zealand white rabbit: cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length. J Orthop Res. 1986; 4(2):221-31. DOI: 10.1002/jor.1100040211. View

15.

Lampropoulou-Adamidou K, Lelovas P, Karadimas E, Liakou C, Triantafillopoulos I, Dontas I . Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol. 2013; 24(3):263-71. DOI: 10.1007/s00590-013-1205-2. View

16.

Seito N, Yamashita T, Tsukuda Y, Matsui Y, Urita A, Onodera T . Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice. Arthritis Rheum. 2012; 64(8):2579-88. PMC: 3382033. DOI: 10.1002/art.34463. View

17.

Kannu P, Bateman J, Belluoccio D, Fosang A, Savarirayan R . Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis. Arthritis Rheum. 2009; 60(2):325-34. DOI: 10.1002/art.24251. View

18.

Murphy L, Schwartz T, Helmick C, Renner J, Tudor G, Koch G . Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008; 59(9):1207-13. PMC: 4516049. DOI: 10.1002/art.24021. View

19.

Ferrari G, Batistatou A, Greene L . Gangliosides rescue neuronal cells from death after trophic factor deprivation. J Neurosci. 1993; 13(5):1879-87. PMC: 6576579. View

20.

Latourte A, Kloppenburg M, Richette P . Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020; 16(12):673-688. DOI: 10.1038/s41584-020-00518-6. View